{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:55:32Z","timestamp":1790610932935,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T00:00:00Z","timestamp":1571616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.biopha.2019.109568","type":"journal-article","created":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T18:37:45Z","timestamp":1581359865000},"page":"109568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Non\u2010coding RNA LOXL1-AS1 exhibits oncogenic activity in ovarian cancer via regulation of miR\u201018b\u20105p\/VMA21 axis"],"prefix":"10.1016","volume":"125","author":[{"given":"Fang","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan Hua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng Cheng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen Li","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai Bin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2019.109568_bib0005","first-page":"1315","article-title":"High expression of lncRNA GACAT3 inhibits invasion and metastasis of non-small cell lung cancer to enhance the effect of radiotherapy","volume":"22","author":"Yang","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2019.109568_bib0010","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.biopha.2018.09.151","article-title":"Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer","volume":"109","author":"Huang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2019.109568_bib0015","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.2147\/CMAR.S194848","article-title":"lncRNA BANCR suppresses cell viability and invasion and promotes apoptosis in non-small-cell lung cancer cells in vitro and in vivo","volume":"11","author":"Yang","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.biopha.2019.109568_bib0020","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.biopha.2017.08.057","article-title":"LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC)","volume":"95","author":"He","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2019.109568_bib0025","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1038\/bjc.2013.548","article-title":"Long non-coding RNA HOTAIR, a driver of malignancy, predicts negative prognosis and exhibits oncogenic activity in oesophageal squamous cell carcinoma","volume":"109","author":"Li","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2019.109568_bib0030","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s13046-019-1364-z","article-title":"LncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus","volume":"38","author":"Jiang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2019.109568_bib0035","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.7150\/thno.20942","article-title":"Long non-coding RNA UICLM promotes colorectal cancer liver metastasis by acting as a ceRNA for microRNA-215 to regulate ZEB2 expression","volume":"7","author":"Chen","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2019.109568_bib0040","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12632","article-title":"Non-coding RNA MFI2-AS1 promotes colorectal cancer cell proliferation, migration and invasion through miR-574-5p\/MYCBP axis","volume":"52","author":"Li","year":"2019","journal-title":"Cell Prolif."},{"key":"10.1016\/j.biopha.2019.109568_bib0045","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12687","article-title":"LncRNA LOXL1-AS1 facilitates the tumorigenesis and stemness of gastric carcinoma via regulation of miR-708-5p\/USF1 pathway","author":"Sun","year":"2019","journal-title":"Cell Prolif."},{"key":"10.1016\/j.biopha.2019.109568_bib0050","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.bbrc.2019.04.089","article-title":"Long non-coding RNA LOXL1-AS1 acts as a ceRNA for miR-324-3p to contribute to cholangiocarcinoma progression via modulation of ATP-binding cassette transporter A1","volume":"513","author":"Zhang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2019.109568_bib0055","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.bbrc.2018.09.160","article-title":"Long noncoding RNA LOXL1-AS1 regulates prostate cancer cell proliferation and cell cycle progression through miR-541-3p and CCND1","volume":"505","author":"Long","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2019.109568_bib0060","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/iub.2075","article-title":"LncRNA LOXL1-AS1\/miR-let-7a-5p\/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells","volume":"71","author":"Bai","year":"2019","journal-title":"IUBMB Life"},{"key":"10.1016\/j.biopha.2019.109568_bib0065","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/jcb.29176","article-title":"lncRNA ZFPM2-AS1 promotes proliferation via miR-18b-5p\/VMA21 axis in lung adenocarcinoma","volume":"121","author":"Xue","year":"2020","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.biopha.2019.109568_bib0070","first-page":"981","article-title":"Long noncoding RNA lncARSR promotes epithelial ovarian cancer cell proliferation and invasion by association with HuR and miR-200 family","volume":"8","author":"Shu","year":"2018","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.biopha.2019.109568_bib0075","doi-asserted-by":"crossref","first-page":"e3118","DOI":"10.1038\/cddis.2017.486","article-title":"The lncRNA HULC functions as an oncogene by targeting ATG7 and ITGB1 in epithelial ovarian carcinoma","volume":"8","author":"Chen","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2019.109568_bib0080","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s13046-018-0910-4","article-title":"Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375\/YAP1 axis","volume":"37","author":"Yan","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2019.109568_bib0085","article-title":"LOXL1-AS1 predicts poor prognosis and promotes cell proliferation, migration, and invasion in osteosarcoma","volume":"39","author":"Chen","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.biopha.2019.109568_bib0090","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bbrc.2018.04.133","article-title":"Silencing LncRNA LOXL1-AS1 attenuates mesenchymal characteristics of glioblastoma via NF-kappaB pathway","volume":"500","author":"Wang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2019.109568_bib0095","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1475-2867-14-47","article-title":"Hsa-miR-574-5p negatively regulates MACC-1 expression to suppress colorectal cancer liver metastasis","volume":"14","author":"Cui","year":"2014","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.biopha.2019.109568_bib0100","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.biopha.2017.09.048","article-title":"MiR-214 inhibits the proliferation and invasion of esophageal squamous cell carcinoma cells by targeting CDC25B","volume":"95","author":"Wang","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2019.109568_bib0105","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bbrc.2017.01.152","article-title":"miR-214 down-regulates ARL2 and suppresses growth and invasion of cervical cancer cells","volume":"484","author":"Peng","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2019.109568_bib0110","doi-asserted-by":"crossref","first-page":"23202","DOI":"10.1002\/jcp.28887","article-title":"Long noncoding RNA AC073284.4 suppresses epithelial-mesenchymal transition by sponging miR-18b-5p in paclitaxel-resistant breast cancer cells","volume":"234","author":"Wang","year":"2019","journal-title":"J. Cell. Physiol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219351911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219351911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:00:52Z","timestamp":1790607652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332219351911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":22,"alternative-id":["S0753332219351911"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109568","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non\u2010coding RNA LOXL1-AS1 exhibits oncogenic activity in ovarian cancer via regulation of miR\u201018b\u20105p\/VMA21 axis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109568","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"109568"}}